We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02620423
Brief Title: Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

First Submitted : November 25, 2015
First Submitted that Met QC Criteria : December 2, 2015
First Posted : December 3, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 12, 2018
Last Update Posted : September 13, 2018